CHIPSA Hospital 2020 Year End Cancer Treatment Review

“In 2021 our protocol may include: HLA mismatched Cellular VG-5000, CAR T-cell therapy, Autologous dendritic cell therapy with or without specific tumor antigens, Natural Killer cell therapy, Personalized tumor lysate vaccine made from the patients tumor, Cellular Nagalase Inhibiting Factor, Intra-tumoral and IV Coley’s toxins, Low dose Insulin potentiated therapy, and Intra-tumoral and IV Apatone.” 2020 […]
Continue reading